Our Mission: Highlighting Innovations by showcasing breakthroughs in cancer research, including diagnostic tools, therapies, and preventive measures.

Lobbying

We are dedicated to advocating for increased funding, policies, and initiatives that drive cancer research and groundbreaking discoveries. Our lobbying efforts focus on supporting leading institutions, organizations, and research centers that are at the forefront of cancer prevention, treatment, and cure.

The Subcommittee on Labor, Health and Human Services, Education, and Related Agencies plays a crucial role in advancing cancer research and allocating federal funding for medical advancements. As a key component of the U.S. House and Senate Appropriations Committees, the subcommittee is responsible for determining budgets for agencies like the National Institutes of Health (NIH) and the National Cancer Institute (NCI), ensuring vital resources are directed toward groundbreaking cancer research, treatment, and prevention initiatives.

By overseeing federal funding for healthcare programs, medical research grants, and public health initiatives, the subcommittee helps drive innovation in cancer therapies, supports clinical trials, and expands access to critical care for patients. It collaborates with research institutions, advocacy groups, and government agencies to prioritize funding for promising cancer breakthroughs, early detection methods, and equitable patient care programs.

Through its budgeting decisions, the subcommittee directly impacts the development of new treatments, emerging technologies, and preventive measures, playing a vital role in the fight against cancer and improving patient outcomes nationwide.

Chair: Robert Aderholt (Alabama)

Office Address: 2358-B Rayburn House Office Building
Phone: (202) 225-3508

Ranking Member: Rosa DeLauro (Connecticut)

Office Address: 2413 Rayburn House Office Building
Phone: (202) 225-3661

MAJORITY MEMBERS:

Mike Simpson (Idaho)

Office Address: 2084 Rayburn House Office Building
Phone: (202) 225-5531

Andy Harris (Maryland)

Office Address: 2334 Rayburn House Office Building
Phone: (202) 225-5311

Chuck Fleischmann (Tennessee)

Office Address: 462 Cannon House Office Building
Phone: (202) 225-3271

John Moolenaar (Michigan)

Office Address: 117 Cannon House Office Building
Phone: (202) 225-3561

Julia Letlow (Louisiana) – Vice Chair

Office Address: 1023 Longworth House Office Building
Phone: (202) 225-8490

Andrew Clyde (Georgia)

Office Address: 521 Cannon House Office Building
Phone: (202) 225-9893

Jake Ellzey (Texas)

Office Address: 1725 Longworth House Office Building
Phone: (202) 225-2002

Stephanie Bice (Oklahoma)

Office Address: 1223 Longworth House Office Building
Phone: (202) 225-2132

Riley Moore (West Virginia)

Office Address: 1508 Longworth House Office Building
Phone: (202) 225-2711

MINORITY MEMBERS:

Steny Hoyer (Maryland)

Office Address: 1705 Longworth House Office Building
Phone: (202) 225-4131

Mark Pocan (Wisconsin)

Office Address: 1727 Longworth House Office Building
Phone: (202) 225-2906

Lois Frankel (Florida)

Office Address: 2305 Rayburn House Office Building
Phone: (202) 225-9890

Bonnie Watson Coleman (New Jersey)

Office Address: 168 Cannon House Office Building
Phone: (202) 225-5801

Rep. Josh Harder (CA)

Office: Address: 209 Cannon House Office Building, Washington, D.C. 20515
Phone: (202) 225-4540

The National Cancer Institute (NCI) makes decisions about cancer research and budgeting through several key groups and individuals. These include:
  1. NCI Director
    The Director of the NCI oversees the institute and makes high-level decisions about its strategic priorities, research direction, and allocation of funds. The Director works closely with the Department of Health and Human Services (HHS) and the National Institutes of Health (NIH).
  2. National Cancer Advisory Board (NCAB
    The NCAB provides advice and recommendations to the NCI Director. It is composed of experts in cancer research, treatment, and advocacy. The board reviews grant applications, budgets, and research priorities to ensure funding is aligned with the NCI’s mission.
  3. Board of Scientific Advisors (BSA)
    The BSA advises on the scientific merits of the NCI’s programs and initiatives. It plays a significant role in assessing the quality of research proposals and recommending which projects should receive funding.
  4. Scientific Program Leaders (SPLs)
    SPLs are responsible for the management of specific research programs and initiatives. They work with program directors and research staff to prioritize projects within their respective domains.
  5. NCI Divisions, Offices, and Centers
    These internal units manage various aspects of cancer research, such as basic science, clinical trials, prevention, and treatment. Decisions about specific research funding are often made within these divisions, based on recommendations from program officers and peer review panels.
  6. Peer Review Committees
    Peer review committees evaluate grant applications submitted to the NCI. These panels, composed of external scientists and experts, make recommendations based on the scientific merit of the proposals.
  7. Congress and Federal Oversigh
    Although not part of the NCI itself, Congress plays a critical role in determining the NCI’s budget through appropriations. The NCI submits budget requests annually, which are reviewed by committees such as the House and Senate Appropriations Committees.

Here are the contact details and relevant links for the key groups and individuals involved in decision-making at the National Cancer Institute (NCI):

Board of Scientific Advisors (BSA)

Address: National Cancer Institute at Shady Grove
Division of Extramural Activities
Committee Management Office
9609 Medical Center Drive
7th Floor, West Tower, Room 7W-412, MSC 9750
Bethesda, MD 20892-9750
Phone: 240-276-6340

National Cancer Advisory Board (NCAB)

Address: National Cancer Institute at Shady Grove
Division of Extramural Activities
Committee Management Office
9609 Medical Center Drive
7th Floor, West Tower, Room 7W-412, MSC 9750
Bethesda, MD 20892-9750
Phone: 240-276-6420

NCI Director

Address: Office of the Director
National Cancer Institute
9609 Medical Center Drive
Bethesda, MD 20892
Phone: 240-276-6340

NCI Scientific Program Leaders (SPLs)

Specific contact details for each program leader are available on the website.

NCI Divisions, Offices, and Centers

Each division, office, and center has its own contact information listed on their respective webpages.

NCI Peer Review Committees

Address: National Cancer Institute at Shady Grove
Division of Extramural Activities
Committee Management Office
9609 Medical Center Drive
7th Floor, West Tower, Room 7W-412, MSC 9750
Bethesda, MD 20892-9750
Phone: 240-276-6420

error: Content is protected !!